Lv41
498 积分 2024-07-29 加入
Lower impact of vonoprazan–amoxicillin dual therapy on gut microbiota forHelicobacter pylorieradication
1小时前
待确认
Long term impact of vonoprazan‐based Helicobacter pylori treatment on gut microbiota and its relation to post‐treatment body weight changes
1小时前
已完结
Effects of amoxicillin dosage on cure rate, gut microbiota, and antibiotic resistome in vonoprazan and amoxicillin dual therapy for Helicobacter pylori: a multicentre, open-label, non-inferiority randomised controlled trial
1小时前
已完结
Comparative effectiveness of potassium-competitive acid blockers and proton pump inhibitors in dual antiplatelet therapy patients: a nationwide cohort study
4天前
已完结
Influence of daily versus alternate-day dosing of vonoprazan on intragastric pH, serum gastrin, and the antiplatelet function of clopidogrel
4天前
已完结
Temporal trends in the treatment of relapsing minimal change podocytopathy – a binational cohort study
4个月前
已完结
Slow Coronary Flow: Pathophysiology, Clinical Implications, and Therapeutic Management
5个月前
已完结
[The expanding needs on lipid-lowering treatment in patients with acute coronary syndrome by applying newly issued definition of extreme high-risk by Chinese Society of Cardiology]
8个月前
已完结
2024 ESC Guidelines for the management of chronic coronary syndromes
10个月前
已完结
Henagliflozin monotherapy in patients with type 2 diabetes inadequately controlled on diet and exercise: A randomized, double‐blind, placebo‐controlled, phase 3 trial
10个月前
已完结
皖公网安备34019202002308
